药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Misoprostol
Deoxyspergualin
The risk or severity of adverse effects can be increased when Everolimus is combined with Deoxyspergualin.
Misoprostol
Doxifluridine
The risk or severity of adverse effects can be increased when Everolimus is combined with Doxifluridine.
Misoprostol
Trofosfamide
The risk or severity of adverse effects can be increased when Everolimus is combined with Trofosfamide.
Misoprostol
Cepeginterferon alfa-2B
The risk or severity of adverse effects can be increased when Everolimus is combined with Cepeginterferon alfa-2B.
Misoprostol
Gusperimus
The risk or severity of adverse effects can be increased when Everolimus is combined with Gusperimus.
Misoprostol
Mizoribine
The risk or severity of adverse effects can be increased when Everolimus is combined with Mizoribine.
Misoprostol
Ozanimod
The risk or severity of adverse effects can be increased when Everolimus is combined with Ozanimod.
Misoprostol
Triptolide
The risk or severity of adverse effects can be increased when Everolimus is combined with Triptolide.
Misoprostol
Ocrelizumab
The risk or severity of adverse effects can be increased when Everolimus is combined with Ocrelizumab.
Misoprostol
Guselkumab
The risk or severity of adverse effects can be increased when Everolimus is combined with Guselkumab.
Misoprostol
Sirukumab
The risk or severity of adverse effects can be increased when Everolimus is combined with Sirukumab.
Misoprostol
Brodalumab
The risk or severity of adverse effects can be increased when Everolimus is combined with Brodalumab.
Misoprostol
Peficitinib
The risk or severity of adverse effects can be increased when Everolimus is combined with Peficitinib.
Misoprostol
Voclosporin
The risk or severity of adverse effects can be increased when Everolimus is combined with Voclosporin.
Misoprostol
Pirarubicin
The risk or severity of adverse effects can be increased when Everolimus is combined with Pirarubicin.
Misoprostol
Ravulizumab
The risk or severity of adverse effects can be increased when Everolimus is combined with Ravulizumab.
Misoprostol
Ixekizumab
The risk or severity of adverse effects can be increased when Everolimus is combined with Ixekizumab.
Misoprostol
Tepoxalin
The risk or severity of adverse effects can be increased when Everolimus is combined with Tepoxalin.
Misoprostol
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Everolimus is combined with Antilymphocyte immunoglobulin (horse).
Misoprostol
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Everolimus is combined with Peginterferon beta-1a.